ContractWarrant Agreement • March 15th, 2012 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION.
ANACOR PHARMACEUTICALS, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENT [VP FORM]Change of Control and Severance Agreement • March 15th, 2012 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California
This Change of Control and Severance Agreement (the “Agreement”) is dated as of , by and between (“Employee”) and Anacor Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Anacor”). This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events.
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 15th, 2012 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS FIRST AMENDMENT to Loan and Security Agreement (this “Amendment”) is entered into as of December 28, 2011, by and among OXFORD FINANCE LLC (successor in interest to Oxford Finance Corporation; in its individual capacity, “Oxford” or “Lender”; in its capacity as Collateral Agent, “Collateral Agent”), HORIZON TECHNOLOGY FINANCE CORPORATION (“HRZN;” individually, a “Lender” and collectively, with Oxford in its capacity as a Lender, the “Lenders”), and ANACOR PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”).
AMENDMENT 3 TO ANACOR PHARMACEUTICALS, INC. ADVISORY BOARD AGREEMENTAdvisory Board Agreement • March 15th, 2012 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment, effective January 1, 2012 (the “Effective Date”), is to Advisory Board Agreement commencing October 1, 2005, and any subsequent Amendments (the “Agreement”) between Anacor Pharmaceuticals, Inc. (“Company”) and Lucy Shapiro, Ph.D.(“Advisor”), together, the Parties.
